Andrew Spaventa - Nov 16, 2023 Form 4 Insider Report for Singular Genomics Systems, Inc. (OMIC)

Role
Chief Executive Officer, Director
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Stock symbol
OMIC
Transactions as of
Nov 16, 2023
Transactions value $
$49,612
Form type
4
Date filed
11/20/2023, 04:31 PM
Previous filing
Sep 15, 2023
Next filing
Dec 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common Stock Purchase $17.9K +43.5K +1.1% $0.41 3.99M Nov 16, 2023 By The Andrew K. Spaventa Living Trust dated April 9, 2014 F1
transaction OMIC Common Stock Purchase $31.8K +75K +1.88% $0.42 4.06M Nov 17, 2023 By The Andrew K. Spaventa Living Trust dated April 9, 2014 F2
holding OMIC Common Stock 9.77K Nov 16, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.3770 to $0.4200, inclusive. The reporting person undertakes to provide to Singular Genomics Systems, Inc., any security holder of Singular Genomics Systems, Inc., or the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.4200 to $0.4456, inclusive. The reporting person undertakes to provide to Singular Genomics Systems, Inc., any security holder of Singular Genomics Systems, Inc., or the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.